Business, energy, technology, markets and global industry news from Business News Today

tumor infiltrating lymphocyte therapy

Pharma & Biotech

Obsidian Therapeutics puts OBX-115 in the spotlight, but is this a real melanoma cell therapy inflection point?

Obsidian Therapeutics will present OBX-115 melanoma data at ASCO 2026. Read why the update matters for TIL therapy, scalability, and solid tumor strategy.

Read More